1	1	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Introduction	_	_	NN	_	_	_	_	_


1	Finding	_	_	VBG	_	_	_	_	_
2	critical	_	_	JJ	_	_	_	_	_
3	in	_	_	FW	_	_	_	_	_
4	vitro	_	_	FW	_	_	_	_	_
5	and/or	_	_	NN	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	silico	_	_	NN	_	_	_	_	_
8	parameters	_	_	NNS	_	_	_	_	_
9	(	_	_	-LRB-	_	_	_	_	_
10	descriptors	_	_	NNS	_	_	_	_	_
11	or	_	_	CC	_	_	_	_	_
12	properties	_	_	NNS	_	_	_	_	_
13	)	_	_	-RRB-	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	hit→lead→seed→drug	_	_	NN	_	_	_	_	_
17	route	_	_	NN	_	_	_	_	_
18	is	_	_	VBZ	_	_	_	_	_
19	still	_	_	RB	_	_	_	_	_
20	a	_	_	DT	_	_	_	_	_
21	long-term	_	_	JJ	_	_	_	_	_
22	aspiration	_	_	NN	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	monumental	_	_	JJ	_	_	_	_	_
25	challenge	_	_	NN	_	_	_	_	_
26	in	_	_	IN	_	_	_	_	_
27	drug	_	_	NN	_	_	_	_	_
28	discovery	_	_	NN	_	_	_	_	_
29	projects	_	_	NNS	_	_	_	_	_
30	,	_	_	,	_	_	_	_	_
31	mainly	_	_	RB	_	_	_	_	_
32	due	_	_	JJ	_	_	_	_	_
33	to	_	_	TO	_	_	_	_	_
34	the	_	_	DT	_	_	_	_	_
35	intrinsic	_	_	JJ	_	_	_	_	_
36	multidimensionality	_	_	NN	_	_	_	_	_
37	of	_	_	IN	_	_	_	_	_
38	the	_	_	DT	_	_	_	_	_
39	problem	_	_	NN	_	_	_	_	_
40	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	concert	_	_	NN	_	_	_	_	_
3	with	_	_	IN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	medicinal	_	_	JJ	_	_	_	_	_
6	chemist	_	_	NN	_	_	_	_	_
7	’s	_	_	POS	_	_	_	_	_
8	intuition	_	_	NN	_	_	_	_	_
9	(	_	_	-LRB-	_	_	_	_	_
10	or	_	_	CC	_	_	_	_	_
11	serendipity	_	_	NN	_	_	_	_	_
12	)	_	_	-RRB-	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	computer-assisted	_	_	JJ	_	_	_	_	_
16	molecular	_	_	JJ	_	_	_	_	_
17	design	_	_	NN	_	_	_	_	_
18	(	_	_	-LRB-	_	_	_	_	_
19	CAMD	_	_	NNP	_	_	_	_	_
20	)	_	_	-RRB-	_	_	_	_	_
21	approaches	_	_	NNS	_	_	_	_	_
22	are	_	_	VBP	_	_	_	_	_
23	regarded	_	_	VBN	_	_	_	_	_
24	as	_	_	IN	_	_	_	_	_
25	an	_	_	DT	_	_	_	_	_
26	integral	_	_	JJ	_	_	_	_	_
27	method	_	_	NN	_	_	_	_	_
28	for	_	_	IN	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	exhaustive	_	_	JJ	_	_	_	_	_
31	transformation	_	_	NN	_	_	_	_	_
32	of	_	_	IN	_	_	_	_	_
33	the	_	_	DT	_	_	_	_	_
34	compound	_	_	NN	_	_	_	_	_
35	topology	_	_	NN	_	_	_	_	_
36	or	_	_	CC	_	_	_	_	_
37	topography	_	_	NN	_	_	_	_	_
38	and/or	_	_	IN	_	_	_	_	_
39	the	_	_	DT	_	_	_	_	_
40	electronic	_	_	JJ	_	_	_	_	_
41	properties	_	_	NNS	_	_	_	_	_
42	into	_	_	IN	_	_	_	_	_
43	the	_	_	DT	_	_	_	_	_
44	property-based	_	_	JJ	_	_	_	_	_
45	chemical	_	_	NN	_	_	_	_	_
46	space	_	_	NN	_	_	_	_	_
47	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	systematic	_	_	JJ	_	_	_	_	_
3	observational	_	_	JJ	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	trends	_	_	NNS	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	structural	_	_	JJ	_	_	_	_	_
8	chemical	_	_	JJ	_	_	_	_	_
9	modifications	_	_	NNS	_	_	_	_	_
10	that	_	_	WDT	_	_	_	_	_
11	produce	_	_	VBP	_	_	_	_	_
12	corresponding	_	_	JJ	_	_	_	_	_
13	changes	_	_	NNS	_	_	_	_	_
14	in	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	biological	_	_	JJ	_	_	_	_	_
17	responses	_	_	NNS	_	_	_	_	_
18	for	_	_	IN	_	_	_	_	_
19	a	_	_	DT	_	_	_	_	_
20	congeneric	_	_	JJ	_	_	_	_	_
21	series	_	_	NN	_	_	_	_	_
22	of	_	_	IN	_	_	_	_	_
23	molecules	_	_	NNS	_	_	_	_	_
24	are	_	_	VBP	_	_	_	_	_
25	fundamental	_	_	JJ	_	_	_	_	_
26	for	_	_	IN	_	_	_	_	_
27	the	_	_	DT	_	_	_	_	_
28	multidimensional	_	_	JJ	_	_	_	_	_
29	quantitative	_	_	JJ	_	_	_	_	_
30	structure	_	_	NN	_	_	_	_	_
31	–	_	_	:	_	_	_	_	_
32	activity	_	_	NN	_	_	_	_	_
33	(	_	_	-LRB-	_	_	_	_	_
34	mD-QSAR	_	_	NN	_	_	_	_	_
35	)	_	_	-RRB-	_	_	_	_	_
36	studies	_	_	NNS	_	_	_	_	_
37	.	_	_	.	_	_	_	_	_


1	Moving	_	_	VBG	_	_	_	_	_
2	from	_	_	IN	_	_	_	_	_
3	complex	_	_	JJ	_	_	_	_	_
4	biological	_	_	JJ	_	_	_	_	_
5	relationships	_	_	NNS	_	_	_	_	_
6	to	_	_	TO	_	_	_	_	_
7	simple	_	_	JJ	_	_	_	_	_
8	QSAR	_	_	NNP	_	_	_	_	_
9	models	_	_	NNS	_	_	_	_	_
10	seems	_	_	VBZ	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	be	_	_	VB	_	_	_	_	_
13	a	_	_	DT	_	_	_	_	_
14	‘	_	_	``	_	_	_	_	_
15	triumph	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	hope	_	_	NN	_	_	_	_	_
18	over	_	_	IN	_	_	_	_	_
19	experience	_	_	NN	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	’	_	_	''	_	_	_	_	_
22	since	_	_	IN	_	_	_	_	_
23	modelers	_	_	NNS	_	_	_	_	_
24	sometimes	_	_	RB	_	_	_	_	_
25	are	_	_	VBP	_	_	_	_	_
26	playing	_	_	VBG	_	_	_	_	_
27	a	_	_	DT	_	_	_	_	_
28	‘	_	_	``	_	_	_	_	_
29	glass	_	_	NN	_	_	_	_	_
30	bead	_	_	NN	_	_	_	_	_
31	game	_	_	NN	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_
33	’	_	_	''	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	quantitative	_	_	JJ	_	_	_	_	_
3	mapping	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	experimental/calculated	_	_	JJ	_	_	_	_	_
6	properties/descriptors	_	_	NNS	_	_	_	_	_
7	into	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	ADMET-driven	_	_	JJ	_	_	_	_	_
10	molecular	_	_	JJ	_	_	_	_	_
11	potency	_	_	NN	_	_	_	_	_
12	is	_	_	VBZ	_	_	_	_	_
13	frequently	_	_	RB	_	_	_	_	_
14	a	_	_	DT	_	_	_	_	_
15	‘	_	_	``	_	_	_	_	_
16	hit-or-miss	_	_	JJ	_	_	_	_	_
17	affair	_	_	NN	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_
19	’	_	_	''	_	_	_	_	_
20	Therefore	_	_	RB	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	some	_	_	DT	_	_	_	_	_
23	structure	_	_	NN	_	_	_	_	_
24	–	_	_	:	_	_	_	_	_
25	activity	_	_	NN	_	_	_	_	_
26	relationship	_	_	NN	_	_	_	_	_
27	(	_	_	-LRB-	_	_	_	_	_
28	SAR)-mediated	_	_	JJ	_	_	_	_	_
29	guides	_	_	NNS	_	_	_	_	_
30	are	_	_	VBP	_	_	_	_	_
31	urgently	_	_	RB	_	_	_	_	_
32	needed	_	_	VBN	_	_	_	_	_
33	at	_	_	IN	_	_	_	_	_
34	the	_	_	DT	_	_	_	_	_
35	‘	_	_	``	_	_	_	_	_
36	pre-synthesis	_	_	JJ	_	_	_	_	_
37	’	_	_	''	_	_	_	_	_
38	stage	_	_	NN	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	Molecular	_	_	JJ	_	_	_	_	_
2	similarity	_	_	NN	_	_	_	_	_
3	is	_	_	VBZ	_	_	_	_	_
4	unarguably	_	_	RB	_	_	_	_	_
5	at	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	core	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	many	_	_	JJ	_	_	_	_	_
10	SAR-based	_	_	JJ	_	_	_	_	_
11	methods	_	_	NNS	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	assuming	_	_	VBG	_	_	_	_	_
14	that	_	_	IN	_	_	_	_	_
15	small	_	_	JJ	_	_	_	_	_
16	variations	_	_	NNS	_	_	_	_	_
17	in	_	_	IN	_	_	_	_	_
18	structure	_	_	NN	_	_	_	_	_
19	lead	_	_	VBP	_	_	_	_	_
20	to	_	_	TO	_	_	_	_	_
21	small	_	_	JJ	_	_	_	_	_
22	changes	_	_	NNS	_	_	_	_	_
23	in	_	_	IN	_	_	_	_	_
24	activity	_	_	NN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	other	_	_	JJ	_	_	_	_	_
3	words	_	_	NNS	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	working	_	_	VBG	_	_	_	_	_
7	tenet	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	QSAR	_	_	NNP	_	_	_	_	_
10	is	_	_	VBZ	_	_	_	_	_
11	that	_	_	IN	_	_	_	_	_
12	molecules	_	_	NNS	_	_	_	_	_
13	with	_	_	IN	_	_	_	_	_
14	high	_	_	JJ	_	_	_	_	_
15	similarity	_	_	NN	_	_	_	_	_
16	share	_	_	VBP	_	_	_	_	_
17	common	_	_	JJ	_	_	_	_	_
18	effects	_	_	NNS	_	_	_	_	_
19	(	_	_	-LRB-	_	_	_	_	_
20	similarity	_	_	NN	_	_	_	_	_
21	principle	_	_	NN	_	_	_	_	_
22	)	_	_	-RRB-	_	_	_	_	_
23	;	_	_	:	_	_	_	_	_
24	however	_	_	RB	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	validity	_	_	NN	_	_	_	_	_
28	of	_	_	IN	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	assumption	_	_	NN	_	_	_	_	_
31	is	_	_	VBZ	_	_	_	_	_
32	still	_	_	RB	_	_	_	_	_
33	questionable	_	_	JJ	_	_	_	_	_
34	—	_	_	:	_	_	_	_	_
35	there	_	_	EX	_	_	_	_	_
36	is	_	_	VBZ	_	_	_	_	_
37	no	_	_	DT	_	_	_	_	_
38	absolute	_	_	JJ	_	_	_	_	_
39	standard	_	_	NN	_	_	_	_	_
40	(	_	_	-LRB-	_	_	_	_	_
41	or	_	_	CC	_	_	_	_	_
42	metric	_	_	NN	_	_	_	_	_
43	)	_	_	-RRB-	_	_	_	_	_
44	of	_	_	IN	_	_	_	_	_
45	similarity	_	_	NN	_	_	_	_	_
46	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	fact	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	similarity	_	_	NN	_	_	_	_	_
5	is	_	_	VBZ	_	_	_	_	_
6	a	_	_	DT	_	_	_	_	_
7	subjective	_	_	JJ	_	_	_	_	_
8	concept	_	_	NN	_	_	_	_	_
9	directly	_	_	RB	_	_	_	_	_
10	related	_	_	VBN	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	aspects	_	_	NNS	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	human	_	_	JJ	_	_	_	_	_
15	cognition	_	_	NN	_	_	_	_	_
16	;	_	_	:	_	_	_	_	_
17	this	_	_	DT	_	_	_	_	_
18	phenomena	_	_	NN	_	_	_	_	_
19	is	_	_	VBZ	_	_	_	_	_
20	sometimes	_	_	RB	_	_	_	_	_
21	called	_	_	VBN	_	_	_	_	_
22	‘	_	_	``	_	_	_	_	_
23	psychological	_	_	JJ	_	_	_	_	_
24	proximity	_	_	NN	_	_	_	_	_
25	’	_	_	''	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	Maggiora	_	_	NNP	_	_	_	_	_
2	’s	_	_	POS	_	_	_	_	_
3	provocative	_	_	JJ	_	_	_	_	_
4	statement	_	_	NN	_	_	_	_	_
5	that	_	_	WDT	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	“	_	_	``	_	_	_	_	_
8	Similarity	_	_	NN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	like	_	_	IN	_	_	_	_	_
11	pornography	_	_	NN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	is	_	_	VBZ	_	_	_	_	_
14	difficult	_	_	JJ	_	_	_	_	_
15	to	_	_	TO	_	_	_	_	_
16	define	_	_	VB	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	but	_	_	CC	_	_	_	_	_
19	you	_	_	PRP	_	_	_	_	_
20	know	_	_	VBP	_	_	_	_	_
21	it	_	_	PRP	_	_	_	_	_
22	when	_	_	WRB	_	_	_	_	_
23	you	_	_	PRP	_	_	_	_	_
24	see	_	_	VBP	_	_	_	_	_
25	it	_	_	PRP	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	”	_	_	''	_	_	_	_	_
28	is	_	_	VBZ	_	_	_	_	_
29	probably	_	_	RB	_	_	_	_	_
30	a	_	_	DT	_	_	_	_	_
31	better	_	_	JJR	_	_	_	_	_
32	illustration	_	_	NN	_	_	_	_	_
33	of	_	_	IN	_	_	_	_	_
34	cognitive	_	_	JJ	_	_	_	_	_
35	aspects	_	_	NNS	_	_	_	_	_
36	of	_	_	IN	_	_	_	_	_
37	similarity	_	_	NN	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_


1	Despite	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	presence	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	fluid	_	_	JJ	_	_	_	_	_
6	scientific	_	_	JJ	_	_	_	_	_
7	boundaries	_	_	NNS	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	e.	_	_	FW	_	_	_	_	_
10	g.	_	_	FW	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	some	_	_	DT	_	_	_	_	_
13	similarity	_	_	NN	_	_	_	_	_
14	metrics	_	_	NNS	_	_	_	_	_
15	exhibit	_	_	VBP	_	_	_	_	_
16	size-dependent	_	_	JJ	_	_	_	_	_
17	behavior	_	_	NN	_	_	_	_	_
18	—	_	_	:	_	_	_	_	_
19	similarity	_	_	NN	_	_	_	_	_
20	quantification	_	_	NN	_	_	_	_	_
21	is	_	_	VBZ	_	_	_	_	_
22	still	_	_	RB	_	_	_	_	_
23	a	_	_	DT	_	_	_	_	_
24	powerful	_	_	JJ	_	_	_	_	_
25	concept	_	_	NN	_	_	_	_	_
26	that	_	_	WDT	_	_	_	_	_
27	allows	_	_	VBZ	_	_	_	_	_
28	us	_	_	PRP	_	_	_	_	_
29	to	_	_	TO	_	_	_	_	_
30	specify	_	_	VB	_	_	_	_	_
31	(	_	_	-LRB-	_	_	_	_	_
32	with	_	_	IN	_	_	_	_	_
33	some	_	_	DT	_	_	_	_	_
34	confidence	_	_	NN	_	_	_	_	_
35	)	_	_	-RRB-	_	_	_	_	_
36	the	_	_	DT	_	_	_	_	_
37	shared	_	_	VBN	_	_	_	_	_
38	host	_	_	NN	_	_	_	_	_
39	–	_	_	:	_	_	_	_	_
40	quest	_	_	NN	_	_	_	_	_
41	interactions	_	_	NNS	_	_	_	_	_
42	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	fact	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	idea	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	specifying	_	_	VBG	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	numerical	_	_	JJ	_	_	_	_	_
10	measure	_	_	NN	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	intermolecular	_	_	JJ	_	_	_	_	_
14	similarity	_	_	NN	_	_	_	_	_
15	based	_	_	VBN	_	_	_	_	_
16	on	_	_	IN	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	degree	_	_	NN	_	_	_	_	_
19	of	_	_	IN	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	resemblance	_	_	NN	_	_	_	_	_
22	between	_	_	IN	_	_	_	_	_
23	two	_	_	CD	_	_	_	_	_
24	objects	_	_	NNS	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	each	_	_	DT	_	_	_	_	_
27	described	_	_	VBN	_	_	_	_	_
28	by	_	_	IN	_	_	_	_	_
29	a	_	_	DT	_	_	_	_	_
30	number	_	_	NN	_	_	_	_	_
31	of	_	_	IN	_	_	_	_	_
32	attributes	_	_	NNS	_	_	_	_	_
33	,	_	_	,	_	_	_	_	_
34	has	_	_	VBZ	_	_	_	_	_
35	been	_	_	VBN	_	_	_	_	_
36	widely	_	_	RB	_	_	_	_	_
37	applied	_	_	VBN	_	_	_	_	_
38	in	_	_	IN	_	_	_	_	_
39	chemical	_	_	JJ	_	_	_	_	_
40	information	_	_	NN	_	_	_	_	_
41	systems	_	_	NNS	_	_	_	_	_
42	.	_	_	.	_	_	_	_	_


1	A	_	_	DT	_	_	_	_	_
2	set	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	characteristics	_	_	NNS	_	_	_	_	_
5	might	_	_	MD	_	_	_	_	_
6	be	_	_	VB	_	_	_	_	_
7	denoted	_	_	VBN	_	_	_	_	_
8	by	_	_	IN	_	_	_	_	_
9	a	_	_	DT	_	_	_	_	_
10	bit-string	_	_	JJ	_	_	_	_	_
11	representation	_	_	NN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	sometimes	_	_	RB	_	_	_	_	_
14	augmented	_	_	VBN	_	_	_	_	_
15	with	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	weighting	_	_	NN	_	_	_	_	_
18	factors	_	_	NNS	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	assigning	_	_	VBG	_	_	_	_	_
21	varying	_	_	VBG	_	_	_	_	_
22	importance	_	_	NN	_	_	_	_	_
23	to	_	_	TO	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	particular	_	_	JJ	_	_	_	_	_
26	descriptors	_	_	NNS	_	_	_	_	_
27	to	_	_	TO	_	_	_	_	_
28	calculate	_	_	VB	_	_	_	_	_
29	a	_	_	DT	_	_	_	_	_
30	quantitative	_	_	JJ	_	_	_	_	_
31	measure	_	_	NN	_	_	_	_	_
32	of	_	_	IN	_	_	_	_	_
33	the	_	_	DT	_	_	_	_	_
34	structural	_	_	JJ	_	_	_	_	_
35	resemblance	_	_	NN	_	_	_	_	_
36	between	_	_	IN	_	_	_	_	_
37	objects	_	_	NNS	_	_	_	_	_
38	,	_	_	,	_	_	_	_	_
39	for	_	_	IN	_	_	_	_	_
40	instance	_	_	NN	_	_	_	_	_
41	Tanimoto	_	_	NNP	_	_	_	_	_
42	coefficient	_	_	NN	_	_	_	_	_
43	.	_	_	.	_	_	_	_	_


1	Obviously	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	a	_	_	DT	_	_	_	_	_
4	crucial	_	_	JJ	_	_	_	_	_
5	question	_	_	NN	_	_	_	_	_
6	that	_	_	WDT	_	_	_	_	_
7	confronts	_	_	VBZ	_	_	_	_	_
8	drug	_	_	NN	_	_	_	_	_
9	‘	_	_	NN	_	_	_	_	_
10	hunters	_	_	NNS	_	_	_	_	_
11	’	_	_	''	_	_	_	_	_
12	is	_	_	VBZ	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	which	_	_	WDT	_	_	_	_	_
15	properties	_	_	NNS	_	_	_	_	_
16	or	_	_	CC	_	_	_	_	_
17	features	_	_	NNS	_	_	_	_	_
18	should	_	_	MD	_	_	_	_	_
19	be	_	_	VB	_	_	_	_	_
20	employed	_	_	VBN	_	_	_	_	_
21	in	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	receptor-dependent	_	_	JJ	_	_	_	_	_
24	(	_	_	-LRB-	_	_	_	_	_
25	RD	_	_	NN	_	_	_	_	_
26	)	_	_	-RRB-	_	_	_	_	_
27	methods	_	_	NNS	_	_	_	_	_
28	that	_	_	WDT	_	_	_	_	_
29	rely	_	_	VBP	_	_	_	_	_
30	on	_	_	IN	_	_	_	_	_
31	the	_	_	DT	_	_	_	_	_
32	principle	_	_	NN	_	_	_	_	_
33	of	_	_	IN	_	_	_	_	_
34	complementarity	_	_	NN	_	_	_	_	_
35	or	_	_	CC	_	_	_	_	_
36	in	_	_	IN	_	_	_	_	_
37	the	_	_	DT	_	_	_	_	_
38	receptor-independent	_	_	JJ	_	_	_	_	_
39	(	_	_	-LRB-	_	_	_	_	_
40	RI	_	_	NNP	_	_	_	_	_
41	)	_	_	-RRB-	_	_	_	_	_
42	ones	_	_	NNS	_	_	_	_	_
43	that	_	_	WDT	_	_	_	_	_
44	are	_	_	VBP	_	_	_	_	_
45	mainly	_	_	RB	_	_	_	_	_
46	based	_	_	VBN	_	_	_	_	_
47	on	_	_	IN	_	_	_	_	_
48	the	_	_	DT	_	_	_	_	_
49	principle	_	_	NN	_	_	_	_	_
50	of	_	_	IN	_	_	_	_	_
51	similarity	_	_	NN	_	_	_	_	_
52	?	_	_	.	_	_	_	_	_


1	Hence	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	many	_	_	JJ	_	_	_	_	_
4	attempts	_	_	NNS	_	_	_	_	_
5	have	_	_	VBP	_	_	_	_	_
6	been	_	_	VBN	_	_	_	_	_
7	undertaken	_	_	VBN	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	order	_	_	NN	_	_	_	_	_
10	to	_	_	TO	_	_	_	_	_
11	implement	_	_	VB	_	_	_	_	_
12	some	_	_	DT	_	_	_	_	_
13	rough	_	_	JJ	_	_	_	_	_
14	guidelines	_	_	NNS	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	sometimes	_	_	RB	_	_	_	_	_
17	called	_	_	VBN	_	_	_	_	_
18	‘	_	_	``	_	_	_	_	_
19	rules	_	_	NNS	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	thumb	_	_	NN	_	_	_	_	_
22	’	_	_	''	_	_	_	_	_
23	for	_	_	IN	_	_	_	_	_
24	both	_	_	CC	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	ligand	_	_	NN	_	_	_	_	_
27	and	_	_	CC	_	_	_	_	_
28	structure-based	_	_	JJ	_	_	_	_	_
29	in	_	_	IN	_	_	_	_	_
30	silico	_	_	NN	_	_	_	_	_
31	protocols	_	_	NNS	_	_	_	_	_
32	;	_	_	:	_	_	_	_	_
33	however	_	_	RB	_	_	_	_	_
34	,	_	_	,	_	_	_	_	_
35	even	_	_	RB	_	_	_	_	_
36	meeting	_	_	VBG	_	_	_	_	_
37	the	_	_	DT	_	_	_	_	_
38	rules	_	_	NNS	_	_	_	_	_
39	does	_	_	VBZ	_	_	_	_	_
40	not	_	_	RB	_	_	_	_	_
41	guarantee	_	_	VB	_	_	_	_	_
42	the	_	_	DT	_	_	_	_	_
43	final	_	_	JJ	_	_	_	_	_
44	success	_	_	NN	_	_	_	_	_
45	of	_	_	IN	_	_	_	_	_
46	drug	_	_	NN	_	_	_	_	_
47	discovery	_	_	NN	_	_	_	_	_
48	projects	_	_	NNS	_	_	_	_	_
49	.	_	_	.	_	_	_	_	_


1	A	_	_	DT	_	_	_	_	_
2	confusing	_	_	JJ	_	_	_	_	_
3	aspect	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	many	_	_	JJ	_	_	_	_	_
6	SAR	_	_	NN	_	_	_	_	_
7	analyses	_	_	NNS	_	_	_	_	_
8	is	_	_	VBZ	_	_	_	_	_
9	that	_	_	IN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	‘	_	_	``	_	_	_	_	_
12	fragile	_	_	JJ	_	_	_	_	_
13	event	_	_	NN	_	_	_	_	_
14	’	_	_	''	_	_	_	_	_
15	can	_	_	MD	_	_	_	_	_
16	occur	_	_	VB	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	when	_	_	WRB	_	_	_	_	_
19	even	_	_	RB	_	_	_	_	_
20	small	_	_	JJ	_	_	_	_	_
21	structural	_	_	JJ	_	_	_	_	_
22	changes	_	_	NNS	_	_	_	_	_
23	(	_	_	-LRB-	_	_	_	_	_
24	colloquially	_	_	RB	_	_	_	_	_
25	termed	_	_	VBN	_	_	_	_	_
26	‘	_	_	``	_	_	_	_	_
27	magic	_	_	JJ	_	_	_	_	_
28	methyl	_	_	NN	_	_	_	_	_
29	’	_	_	''	_	_	_	_	_
30	)	_	_	-RRB-	_	_	_	_	_
31	can	_	_	MD	_	_	_	_	_
32	result	_	_	VB	_	_	_	_	_
33	in	_	_	IN	_	_	_	_	_
34	a	_	_	DT	_	_	_	_	_
35	boost	_	_	NN	_	_	_	_	_
36	of	_	_	IN	_	_	_	_	_
37	potency	_	_	NN	_	_	_	_	_
38	for	_	_	IN	_	_	_	_	_
39	the	_	_	DT	_	_	_	_	_
40	target	_	_	NN	_	_	_	_	_
41	,	_	_	,	_	_	_	_	_
42	or	_	_	CC	_	_	_	_	_
43	in	_	_	IN	_	_	_	_	_
44	a	_	_	DT	_	_	_	_	_
45	more	_	_	RBR	_	_	_	_	_
46	detrimental	_	_	JJ	_	_	_	_	_
47	manner	_	_	NN	_	_	_	_	_
48	,	_	_	,	_	_	_	_	_
49	can	_	_	MD	_	_	_	_	_
50	completely	_	_	RB	_	_	_	_	_
51	destroy	_	_	VB	_	_	_	_	_
52	biological	_	_	JJ	_	_	_	_	_
53	response	_	_	NN	_	_	_	_	_
54	—	_	_	:	_	_	_	_	_
55	a	_	_	DT	_	_	_	_	_
56	phenomenon	_	_	NN	_	_	_	_	_
57	known	_	_	VBN	_	_	_	_	_
58	as	_	_	IN	_	_	_	_	_
59	activity	_	_	NN	_	_	_	_	_
60	‘	_	_	``	_	_	_	_	_
61	hotspot	_	_	NN	_	_	_	_	_
62	’	_	_	''	_	_	_	_	_
63	or	_	_	CC	_	_	_	_	_
64	activity	_	_	NN	_	_	_	_	_
65	‘	_	_	``	_	_	_	_	_
66	cliff	_	_	NN	_	_	_	_	_
67	’	_	_	''	_	_	_	_	_
68	in	_	_	IN	_	_	_	_	_
69	structure-activity	_	_	JJ	_	_	_	_	_
70	landscape	_	_	NN	_	_	_	_	_
71	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	other	_	_	JJ	_	_	_	_	_
3	words	_	_	NNS	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	finding	_	_	VBG	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	optimal	_	_	JJ	_	_	_	_	_
8	balance	_	_	NN	_	_	_	_	_
9	between	_	_	IN	_	_	_	_	_
10	ADMET-related	_	_	JJ	_	_	_	_	_
11	properties	_	_	NNS	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	desired	_	_	VBN	_	_	_	_	_
14	drug	_	_	NN	_	_	_	_	_
15	potency	_	_	NN	_	_	_	_	_
16	(	_	_	-LRB-	_	_	_	_	_
17	‘	_	_	``	_	_	_	_	_
18	sweet	_	_	JJ	_	_	_	_	_
19	spot	_	_	NN	_	_	_	_	_
20	’	_	_	''	_	_	_	_	_
21	)	_	_	-RRB-	_	_	_	_	_
22	can	_	_	MD	_	_	_	_	_
23	be	_	_	VB	_	_	_	_	_
24	rationalized	_	_	VBN	_	_	_	_	_
25	graphically	_	_	RB	_	_	_	_	_
26	by	_	_	IN	_	_	_	_	_
27	extension	_	_	NN	_	_	_	_	_
28	of	_	_	IN	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	2D	_	_	JJ	_	_	_	_	_
31	similarity-based	_	_	JJ	_	_	_	_	_
32	projection	_	_	NN	_	_	_	_	_
33	with	_	_	IN	_	_	_	_	_
34	activity	_	_	NN	_	_	_	_	_
35	data	_	_	NNS	_	_	_	_	_
36	in	_	_	IN	_	_	_	_	_
37	the	_	_	DT	_	_	_	_	_
38	form	_	_	NN	_	_	_	_	_
39	of	_	_	IN	_	_	_	_	_
40	a	_	_	DT	_	_	_	_	_
41	‘	_	_	``	_	_	_	_	_
42	biological	_	_	JJ	_	_	_	_	_
43	response	_	_	NN	_	_	_	_	_
44	surface	_	_	NN	_	_	_	_	_
45	’	_	_	''	_	_	_	_	_
46	or	_	_	CC	_	_	_	_	_
47	SAR	_	_	NN	_	_	_	_	_
48	landscapes	_	_	NNS	_	_	_	_	_
49	.	_	_	.	_	_	_	_	_


1	Intuitively	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	we	_	_	PRP	_	_	_	_	_
4	feel	_	_	VBP	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	structure	_	_	NN	_	_	_	_	_
8	–	_	_	:	_	_	_	_	_
9	activity	_	_	NN	_	_	_	_	_
10	landscapes	_	_	NNS	_	_	_	_	_
11	are	_	_	VBP	_	_	_	_	_
12	heterogeneous	_	_	JJ	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	nature	_	_	NN	_	_	_	_	_
15	with	_	_	IN	_	_	_	_	_
16	unevenly	_	_	RB	_	_	_	_	_
17	distributed	_	_	VBN	_	_	_	_	_
18	regions	_	_	NNS	_	_	_	_	_
19	that	_	_	WDT	_	_	_	_	_
20	are	_	_	VBP	_	_	_	_	_
21	reminiscent	_	_	JJ	_	_	_	_	_
22	of	_	_	IN	_	_	_	_	_
23	Tolkien	_	_	NNP	_	_	_	_	_
24	’s	_	_	POS	_	_	_	_	_
25	Misty	_	_	NNP	_	_	_	_	_
26	Mountains	_	_	NNP	_	_	_	_	_
27	with	_	_	IN	_	_	_	_	_
28	gently	_	_	RB	_	_	_	_	_
29	slopes	_	_	NNS	_	_	_	_	_
30	,	_	_	,	_	_	_	_	_
31	steep	_	_	JJ	_	_	_	_	_
32	cliffs	_	_	NNS	_	_	_	_	_
33	and	_	_	CC	_	_	_	_	_
34	stony	_	_	JJ	_	_	_	_	_
35	bridges	_	_	NNS	_	_	_	_	_
36	.	_	_	.	_	_	_	_	_


1	Geographically	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	a	_	_	DT	_	_	_	_	_
4	successful	_	_	JJ	_	_	_	_	_
5	voyage	_	_	NN	_	_	_	_	_
6	(	_	_	-LRB-	_	_	_	_	_
7	or	_	_	CC	_	_	_	_	_
8	exploration	_	_	NN	_	_	_	_	_
9	)	_	_	-RRB-	_	_	_	_	_
10	requires	_	_	VBZ	_	_	_	_	_
11	a	_	_	DT	_	_	_	_	_
12	map	_	_	NN	_	_	_	_	_
13	indicating	_	_	VBG	_	_	_	_	_
14	smooth	_	_	JJ	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	flat	_	_	JJ	_	_	_	_	_
17	regions	_	_	NNS	_	_	_	_	_
18	that	_	_	WDT	_	_	_	_	_
19	are	_	_	VBP	_	_	_	_	_
20	easy	_	_	JJ	_	_	_	_	_
21	to	_	_	TO	_	_	_	_	_
22	navigate	_	_	VB	_	_	_	_	_
23	or	_	_	CC	_	_	_	_	_
24	jagged	_	_	VBN	_	_	_	_	_
25	parts	_	_	NNS	_	_	_	_	_
26	that	_	_	WDT	_	_	_	_	_
27	are	_	_	VBP	_	_	_	_	_
28	tough	_	_	JJ	_	_	_	_	_
29	to	_	_	TO	_	_	_	_	_
30	traverse	_	_	VB	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	Chemically	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	gently	_	_	RB	_	_	_	_	_
4	sloped	_	_	VBN	_	_	_	_	_
5	hills	_	_	NNS	_	_	_	_	_
6	pinpoint	_	_	VBP	_	_	_	_	_
7	areas	_	_	NNS	_	_	_	_	_
8	where	_	_	WRB	_	_	_	_	_
9	gradual	_	_	JJ	_	_	_	_	_
10	structural	_	_	JJ	_	_	_	_	_
11	variations	_	_	NNS	_	_	_	_	_
12	are	_	_	VBP	_	_	_	_	_
13	accompanied	_	_	VBN	_	_	_	_	_
14	by	_	_	IN	_	_	_	_	_
15	moderate	_	_	JJ	_	_	_	_	_
16	changes	_	_	NNS	_	_	_	_	_
17	in	_	_	IN	_	_	_	_	_
18	activity	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	whereas	_	_	IN	_	_	_	_	_
21	in	_	_	IN	_	_	_	_	_
22	flat	_	_	JJ	_	_	_	_	_
23	SAR	_	_	NN	_	_	_	_	_
24	landscapes	_	_	NNS	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	biological	_	_	JJ	_	_	_	_	_
28	data	_	_	NN	_	_	_	_	_
29	varies	_	_	VBZ	_	_	_	_	_
30	little	_	_	JJ	_	_	_	_	_
31	over	_	_	IN	_	_	_	_	_
32	the	_	_	DT	_	_	_	_	_
33	wide	_	_	JJ	_	_	_	_	_
34	modifications	_	_	NNS	_	_	_	_	_
35	in	_	_	IN	_	_	_	_	_
36	the	_	_	DT	_	_	_	_	_
37	compound	_	_	NN	_	_	_	_	_
38	structure	_	_	NN	_	_	_	_	_
39	—	_	_	:	_	_	_	_	_
40	further	_	_	JJR	_	_	_	_	_
41	substitutions	_	_	NNS	_	_	_	_	_
42	are	_	_	VBP	_	_	_	_	_
43	not	_	_	RB	_	_	_	_	_
44	likely	_	_	JJ	_	_	_	_	_
45	to	_	_	TO	_	_	_	_	_
46	result	_	_	VB	_	_	_	_	_
47	in	_	_	IN	_	_	_	_	_
48	more	_	_	RBR	_	_	_	_	_
49	potent	_	_	JJ	_	_	_	_	_
50	molecules	_	_	NNS	_	_	_	_	_
51	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	fact	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	disallowed	_	_	VBN	_	_	_	_	_
5	structural	_	_	JJ	_	_	_	_	_
6	modifications	_	_	NNS	_	_	_	_	_
7	can	_	_	MD	_	_	_	_	_
8	be	_	_	VB	_	_	_	_	_
9	highlighted	_	_	VBN	_	_	_	_	_
10	in	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	sharply	_	_	RB	_	_	_	_	_
13	non-uniform	_	_	JJ	_	_	_	_	_
14	regions	_	_	NNS	_	_	_	_	_
15	where	_	_	WRB	_	_	_	_	_
16	chemically	_	_	RB	_	_	_	_	_
17	related	_	_	VBN	_	_	_	_	_
18	compounds	_	_	NNS	_	_	_	_	_
19	are	_	_	VBP	_	_	_	_	_
20	characterized	_	_	VBN	_	_	_	_	_
21	by	_	_	IN	_	_	_	_	_
22	huge	_	_	JJ	_	_	_	_	_
23	response	_	_	NN	_	_	_	_	_
24	variations	_	_	NNS	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	forming	_	_	VBG	_	_	_	_	_
27	steep	_	_	JJ	_	_	_	_	_
28	cliffs	_	_	NNS	_	_	_	_	_
29	in	_	_	IN	_	_	_	_	_
30	the	_	_	DT	_	_	_	_	_
31	activity	_	_	NN	_	_	_	_	_
32	landscape	_	_	NN	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	Moreover	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	chemical	_	_	JJ	_	_	_	_	_
4	bridges	_	_	NNS	_	_	_	_	_
5	can	_	_	MD	_	_	_	_	_
6	be	_	_	VB	_	_	_	_	_
7	observed	_	_	VBN	_	_	_	_	_
8	with	_	_	IN	_	_	_	_	_
9	molecules	_	_	NNS	_	_	_	_	_
10	connecting	_	_	VBG	_	_	_	_	_
11	different	_	_	JJ	_	_	_	_	_
12	local	_	_	JJ	_	_	_	_	_
13	SAR	_	_	NN	_	_	_	_	_
14	models	_	_	NNS	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	detection	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	activity	_	_	NN	_	_	_	_	_
6	hotspots	_	_	NNS	_	_	_	_	_
7	provides	_	_	VBZ	_	_	_	_	_
8	reasonable	_	_	JJ	_	_	_	_	_
9	hints	_	_	NNS	_	_	_	_	_
10	to	_	_	TO	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	key	_	_	JJ	_	_	_	_	_
13	question	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	medicinal	_	_	JJ	_	_	_	_	_
16	chemistry	_	_	NN	_	_	_	_	_
17	regarding	_	_	VBG	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	impact	_	_	NN	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	molecule	_	_	NN	_	_	_	_	_
22	rearrangement	_	_	NN	_	_	_	_	_
23	on	_	_	IN	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	activity	_	_	NN	_	_	_	_	_
26	profile	_	_	NN	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	numerical	_	_	JJ	_	_	_	_	_
3	quantification	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	activity	_	_	NN	_	_	_	_	_
6	cliffs	_	_	NNS	_	_	_	_	_
7	is	_	_	VBZ	_	_	_	_	_
8	frequently	_	_	RB	_	_	_	_	_
9	performed	_	_	VBN	_	_	_	_	_
10	using	_	_	VBG	_	_	_	_	_
11	a	_	_	DT	_	_	_	_	_
12	variety	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	fingerprint	_	_	NN	_	_	_	_	_
15	representations	_	_	NNS	_	_	_	_	_
16	or	_	_	CC	_	_	_	_	_
17	similarity	_	_	NN	_	_	_	_	_
18	metrics	_	_	NNS	_	_	_	_	_
19	;	_	_	:	_	_	_	_	_
20	for	_	_	IN	_	_	_	_	_
21	instance	_	_	NN	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	the	_	_	DT	_	_	_	_	_
24	structure	_	_	NN	_	_	_	_	_
25	–	_	_	:	_	_	_	_	_
26	activity	_	_	NN	_	_	_	_	_
27	landscape	_	_	NN	_	_	_	_	_
28	index	_	_	NN	_	_	_	_	_
29	(	_	_	-LRB-	_	_	_	_	_
30	SALI	_	_	NNP	_	_	_	_	_
31	)	_	_	-RRB-	_	_	_	_	_
32	has	_	_	VBZ	_	_	_	_	_
33	been	_	_	VBN	_	_	_	_	_
34	proposed	_	_	VBN	_	_	_	_	_
35	to	_	_	TO	_	_	_	_	_
36	evaluate	_	_	VB	_	_	_	_	_
37	SAR	_	_	NN	_	_	_	_	_
38	smoothness	_	_	NN	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_

